Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bristol-Myers Squibb
PrECOG, LLC.
Cedars-Sinai Medical Center
AstraZeneca
AstraZeneca
Chinese University of Hong Kong
Guangdong Association of Clinical Trials
Genprex, Inc.
Nuvectis Pharma, Inc.
Dizal Pharmaceuticals
Ohio State University Comprehensive Cancer Center
SWOG Cancer Research Network
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Shanghai Hengrui Pharmaceutical Co., Ltd.
Wayshine Biopharm, Inc.
AstraZeneca
Memorial Sloan Kettering Cancer Center
Avistone Biotechnology Co., Ltd.
Emory University
Sichuan Baili Pharmaceutical Co., Ltd.
City of Hope Medical Center
Shanghai JMT-Bio Inc.
DualityBio Inc.
Goethe University
China Medical University Hospital
Hunan Province Tumor Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Region Skane
Hunan Province Tumor Hospital
Instituto Oncológico Dr Rosell
Sun Yat-sen University